Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Announces FDA Expanded Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Individuals under the Age of 12
Investegate announcements from Junshi Biosciences, Junshi Biosciences Announces FDA Expanded Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Individuals under the Age of 12
Source: investegate.co.uk